Latest News

Alzheimer's prevention trial to monitor reactions to higher disease risk status

A new clinical trial will soon begin testing whether early medical intervention in people at risk for Alzheimer's can slow down progression of disease pathology before symptoms emerge. As part of the overall prevention trial, neurodegenerative ethics experts will monitor how learning about their risk of developing Alzheimer's impacts trial participants.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Patient-doctor ethnic differences thwart end-of-life conversations

  • Verbal therapy could block consolidation of fear memories in trauma victims

  • Nerve cells, blood vessels in eye 'talk' to prevent disease

  • Locusts provide insight into brain response to stimuli, senses

  • Finding the body clock's molecular reset button

  • Breakthrough in understanding Canavan disease

  • Your adolescent brain on alcohol: Changes last into adulthood

  • Hate to diet? It's how we're wired

  • Brain balances perception and action when caught in an illusion

  • A 'GPS' to navigate the brain's neuronal networks

  •